Teva charged in DoJ antitrust probe into generic drug price-fixing
26-08-2020
US states sue 26 drugmakers over alleged price fixing
11-06-2020
Par avoids pay-for-delay suit after court accepts payment was ‘fair’
10-03-2020
Pavel Kapysh / Shutterstock.com
Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Glenmark, Pharmaceuticals, generic, antitrust, violations, US Antitrust Division, Pravastatin, Apotex, US Department of Justice, price-fixing
